Literature DB >> 12471197

Risk assessment and management of high risk familial breast cancer.

D G R Evans1, F Lalloo.   

Abstract

The demand for genetic services by women with a family history of breast cancer has increased exponentially over the last few years. It is important that risks to women are accurately assessed and that processes are in place for appropriate counselling and management. The classification of risk into average, moderate, and high, depending upon the assessed lifetime risk of breast cancer, allows for the management of moderate risk women within cancer units and high risk women within the regional genetic centres. Management of high risk women includes discussion of options including screening, chemoprevention, and preventive surgery. The majority of these options are still unproven in the long term and continuing research is needed for their evaluation. Mutation screening and predictive testing are now a reality for a minority of families, allowing for a more informed basis for decisions regarding management options.

Entities:  

Mesh:

Year:  2002        PMID: 12471197      PMCID: PMC1757211          DOI: 10.1136/jmg.39.12.865

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  84 in total

1.  Will the real Cowden syndrome please stand up: revised diagnostic criteria.

Authors:  C Eng
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

2.  Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

Authors:  J Brown; D Buckley; A Coulthard; A K Dixon; J M Dixon; D F Easton; R A Eeles; D G Evans; F G Gilbert; M Graves; C Hayes; J P Jenkins; A P Jones; S F Keevil; M O Leach; G P Liney; S M Moss; A R Padhani; G J Parker; L J Pointon; B A Ponder; T W Redpath; J P Sloane; L W Turnbull; L G Walker; R M Warren
Journal:  Magn Reson Imaging       Date:  2000-09       Impact factor: 2.546

3.  Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

Authors:  A B Miller; T To; C J Baines; C Wall
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

4.  Male breast cancer in Cowden syndrome patients with germline PTEN mutations.

Authors:  J D Fackenthal; D J Marsh; A L Richardson; S A Cummings; C Eng; B G Robinson; O I Olopade
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

5.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  H Meijers-Heijboer; B van Geel; W L van Putten; S C Henzen-Logmans; C Seynaeve; M B Menke-Pluymers; C C Bartels; L C Verhoog; A M van den Ouweland; M F Niermeijer; C T Brekelmans; J G Klijn
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

6.  Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

Authors:  C T Brekelmans; C Seynaeve; C C Bartels; M M Tilanus-Linthorst; E J Meijers-Heijboer; C M Crepin; A A van Geel; M Menke; L C Verhoog; A van den Ouweland; I M Obdeijn; J G Klijn
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

7.  Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes.

Authors:  P Hopwood; A Lee; A Shenton; A Baildam; A Brain; F Lalloo; G Evans; A Howell
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

8.  A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.

Authors:  F Lalloo; A Baildam; A Brain; P Hopwood; D G Evans; A Howell
Journal:  Eur J Surg Oncol       Date:  2000-11       Impact factor: 4.424

9.  Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.

Authors:  J M Varley; G McGown; M Thorncroft; L A James; G P Margison; G Forster; D G Evans; M Harris; A M Kelsey; J M Birch
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

10.  Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Authors:  D Thompson; D Easton
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

View more
  14 in total

1.  The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview Survey.

Authors:  C P Gross; G Filardo; H S Singh; A N Freedman; M H Farrell
Journal:  J Gen Intern Med       Date:  2005-12-22       Impact factor: 5.128

Review 2.  Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.

Authors:  R N Moule; S G Jhavar; R A Eeles
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

3.  Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry.

Authors:  Li Rita Zhang; Anna M Chiarelli; Gord Glendon; Lucia Mirea; Sarah Edwards; Julia A Knight; Irene L Andrulis; Paul Ritvo
Journal:  Eur J Cancer Prev       Date:  2011-07       Impact factor: 2.497

4.  Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.

Authors:  Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

5.  Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry.

Authors:  Meghan J Walker; Lucia Mirea; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight; Anna M Chiarelli
Journal:  Breast       Date:  2014-05-10       Impact factor: 4.380

6.  Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.

Authors:  E Amir; D G Evans; A Shenton; F Lalloo; A Moran; C Boggis; M Wilson; A Howell
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

Review 7.  Nipple-sparing mastectomy in women at high risk of developing breast cancer.

Authors:  Rebecca S Lewis; Angela George; Jennifer E Rusby
Journal:  Gland Surg       Date:  2018-06

8.  The information and support needs of women at high risk of familial breast and ovarian cancer: how can cancer genetic services give patients what they want?

Authors:  Rachel Iredale; Kate Brain; Jonathon Gray; Elizabeth France
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

9.  Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry.

Authors:  Paul Ritvo; Sarah A Edwards; Gord Glendon; Lucia Mirea; Julia A Knight; Irene L Andrulis; Anna M Chiarelli
Journal:  BMC Public Health       Date:  2012-07-12       Impact factor: 3.295

10.  Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme.

Authors:  D Gareth R Evans; Sarah Ingham; Sarah Dawe; L Roberts; F Lalloo; A R Brentnall; P Stavrinos; Anthony Howell
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.